Pricing Cancer Drugs: When Does Pricing Become Profiteering?

Overview of attention for article published in The AMA Journal of Ethic, August 2015

Altmetric Badge

Mentioned by

twitter: 19 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Application of the Failure Mode and Effects Analysis (FMEA) to identify vulnerabilities and opportunities for improvement prior to implementing a computerized prescription order entry (CPOE) system in a university hospital oncology clinic

Article in Journal of Oncology Pharmacy Practice (November 2021)

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

Article in JAMA Network Open (January 2019)

Dealing with the spiralling price of medicines: issues and solutions

Article in Internal Medicine Journal (January 2018)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.